Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Treatment Selection for HR+ mBC

mBC: CDK4/6 Inhibitor Patient Selection/Sequencing

CDK4/6 Inhibitors in Breast Cancer: Ongoing Research

FDA Approval for Abemaciclib

MONARCH 3: Abemaciclib With Endocrine Therapy for mBC

MONARCH 1: Abemaciclib Monotherapy for HR+ mBC

Abemaciclib + Fulvestrant at Progression of HR+ mBC

Abemaciclib for ER+ mBC

CDK4/6 Inhibitors: Managing Toxicity in HR+ mBC

Clinical Experience: CDK4/6 Inhibitors in Breast Cancer

CDK 4/6 Inhibitors in Metastatic Breast Cancer

Future Directions in NSCLC Immuno-Oncology Research

Immuno-Oncology Combination Therapy in NSCLC

Promising Immunotherapy Agents for NSCLC

PACIFIC Trial: Durvalumab for Stage 3 NSCLC

Immunotherapy for Management of Stage 3B NSCLC

Immunotherapy Toxicity Management in NSCLC

Treatment for NSCLC After Progression on Immunotherapy

Combination Approaches for Second-Line Therapy for NSCLC

The Role of Mutation Burden as a Biomarker in NSCLC

Immuno-Oncology

Immuno-Oncology | Specialty